Anzeige
Mehr »
Login
Dienstag, 16.04.2024 Börsentäglich über 12.000 News von 689 internationalen Medien
Biotech-Perle kurz vor entscheidender Meilenstein-Meldung!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2P5N7 | ISIN: FI4000330972 | Ticker-Symbol: 4YL
Frankfurt
16.04.24
08:28 Uhr
2,555 Euro
+0,045
+1,79 %
Branche
Nanotechnologie
Aktienmarkt
Sonstige
1-Jahres-Chart
NANOFORM FINLAND OYJ Chart 1 Jahr
5-Tage-Chart
NANOFORM FINLAND OYJ 5-Tage-Chart
RealtimeGeldBriefZeit
2,5302,57509:23

Aktuelle News zur NANOFORM FINLAND Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
09.04.Nanoform and PlusVitech partner to repurpose aprepitant as a treatment for lung cancer299Nanoform Finland Plc April 9, 2024 09.00 EEST / 08.00 CEST HELSINKI, April 9, 2024 /PRNewswire/ -- Nanoform Finland Plc ("Nanoform"), the medicine performance-enhancing company...
► Artikel lesen
26.03.The Board of Directors of Nanoform Finland Plc decided on issue of stock options to key individuals1
12.03.Notice to the Annual General Meeting of NANOFORM FINLAND Plc1
12.03.Share subscriptions based on Nanoform Finland Plc's stock options 2/2019 and 1/20201
06.03.Nanoform Finland Plc - Manager's transactions - Miguel Calado2
06.03.Nanoform Finland Plc - Manager's transactions - Mads Laustsen1
06.03.Nanoform Finland Plc - Manager's transactions - Albert Hæggström2
06.03.Nanoform Finland Plc - Manager's transactions - Jeanne Thoma1
29.02.NANOFORM: Strong momentum in Project Nanoenzalutamide1
16.02.Invitation to Nanoform's Q4 and FY 2023 Report Presentation1
15.02.Inside information made public: Nanoform Wins R&D Grant of EUR 4.3M for Research Into Nanoparticle Enabled Formulations for Next Generation Medicines555THIS PRESS RELEASE CONTAINS INFORMATION THAT NANOFORM IS OBLIGED TO MAKE PUBLIC PURSUANT TO THE EU MARKET ABUSE REGULATION. THE INFORMATION WAS SENT FOR PUBLICATION THROUGH THE AGENCY OF...
► Artikel lesen
26.01.Inside information made public: Nanoform Announces Important Milestone with Promising Clinical Results for Patient-Centric Nanotechnology-Enhanced Enzalutamide626THIS PRESS RELEASE CONTAINS INFORMATION THAT NANOFORM IS OBLIGED TO MAKE PUBLIC PURSUANT TO THE EU MARKET ABUSE REGULATION. THE INFORMATION WAS SENT FOR PUBLICATION THROUGH THE AGENCY OF...
► Artikel lesen
10.01.Nanoform Finland Plc - Manager's transactions - Albert Hæggström1
10.01.The Board of Directors of Nanoform Finland Plc decided on issue of stock options under an option program open to all employees2
10.01.Nanoform Finland Plc - Manager's transactions - David Rowe2
10.01.Nanoform Finland Plc - Manager's transactions - Johanna Kause2
10.01.Nanoform Finland Plc - Manager's transactions - Edward Hæggström1
10.01.Nanoform Finland Plc - Manager's transactions - Antonio Da Silva1
10.01.Nanoform Finland Plc - Manager's transactions - Peter Hänninen3
10.01.Nanoform Finland Plc - Manager's transactions - Christian Jones1
Seite:  Weiter >>
33 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1